Prenatal and Newborn Genetic Testing Market is expected to reach US$ 11,204.74 Mn by 2027

1
Prenatal and Newborn Genetic Testing Market 
Prenatal and Newborn Genetic Testing Market to
2027 - Global Analysis and Forecasts By Product
(Diagnostic, and Screening), Disease (Cystic
Fibrosis, Sickle Cell Anemia, Downs Syndrome,
Phenylketonuria, and Other Disease), End User
(Hospitals and Clinics, Diagnostic Centers, and
Other End User) and Geography
2
Current and future Market Scenario
Prenatal and Newborn Genetic Testing Market 
According to The Insight Partners market research
study titled Prenatal and Newborn Genetic Testing
Market - Global Analysis and Forecasts by
Product, Disease Indication and End User. The
Global Prenatal and Newborn Genetic Testing
Market is expected to reach US 11,204.7 Mn in
2027 from US 4,034.4 in 2018. The market is
estimated to grow with a CAGR of 12.2 from
2019-2027. The report highlights the trends
prevalent in the global prenatal and newborn
genetic testing market and the factors driving
the market along with those that act as
deterrents to its growth.
3
Market Segments
Prenatal and Newborn Genetic Testing Market   
By Product Diagnostic Spectrophotometer Polymera
se Chain Reaction Fluorescence in-situ
Hybridization Array-Comparative Genomic
Hybridization
By Disease Indication Cystic Fibrosis Sickle Cell
Anemia Down Syndrome Phenylketonuria Other
Diseases
By End User Hospitals Clinics Diagnostic
Centres Other End Users
4
Leading Players
Prenatal and Newborn Genetic Testing Market  
Company Profiles in Prenatal and Newborn Genetic
Testing Market are Abbott Quest Diagnostics
Incorporated Ravgen Bio-Rad Laboratories,
Inc., Illumina, Inc. F. Hoffmann La-Roche
Ltd. Qiagen Berry Gene PerkinElmer, Inc. Natera,
Inc. Laboratory Corporation of America Holdings
(Sequenom)
5
Prenatal and Newborn Genetic Testing
Market  
Access Full Research Report at
https//www.theinsightpartners.com/reports/prenata
l-and-newborn-genetic-testing-market
Thank You!

• Thank You!